Malaysia to allow commercial sale of COVID-19 vaccines

3 minute read

Signage of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang//File Photo

Register now for FREE unlimited access to Reuters.com

KUALA LUMPUR, July 16 (Reuters) - Malaysia will soon allow the commercial sale of COVID-19 vaccines manufactured by Chinese firms Sinopharm (1099.HK) and Sinovac (SVA.O), the science minister said on Friday, as authorities try to ramp up inoculation rates amid surging cases.

Malaysia has one of the region's highest number of coronavirus infections per-capita but also one of its fastest vaccination rates. About 39% of its adult population has received at least one dose of a COVID-19 vaccine.

The Sinopharm vaccine, which Malaysia approved on Friday for emergency use, would soon be open for private purchase, science minister Khairy Jamaluddin told a virtual news conference.

Register now for FREE unlimited access to Reuters.com

Meanwhile, Sinovac vaccines would be available commercially from Aug. 1, after it has completed the delivery of some 15 million doses procured by the government, he said.

Malaysia on Friday reported 12,541 new coronavirus cases, bringing total infections to 893,323, including 6,728 deaths.

Malaysia had previously said it would stop administering Sinovac vaccines after supplies run out, and would instead rely largely on the Pfizer-BioNTech (PFE.N), (22UAy.DE) mRNA vaccine for its national rollout. read more

On Friday, Khairy clarified that surplus Sinovac shots would remain available for those who may have allergy concerns with other vaccines.

"There is no issue over Sinovac's efficacy," he said.

Malaysia would also consider purchasing more doses from Sinovac in the event of a shortfall of AstraZeneca vaccines from neighbouring Thailand, Khairy said.

Thailand said this week it was considering limiting exports of locally-produced AstraZeneca vaccines to fight its own COVID-19 crisis, a move that could potentially disrupt supplies to its regional neighbours. read more

Khairy said Malaysia would seek assurances from Thailand that there would be no disruptions to supply.

Register now for FREE unlimited access to Reuters.com
Reporting by Rozanna Latiff Editing by Raissa Kasolowsky

Our Standards: The Thomson Reuters Trust Principles.